Distribution and Excretion Flashcards

1
Q

Mode of Administration: oral or rectal for GI imaging

A

Metallic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Absorption: Not absorbed by the GI tract; remains within the lumen

A

Metallic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Distribution: Localized in the GI tract for visualization of pathologies

A

Metallic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metabolism: Not metabolized by the body due to its insolubility

A

Metallic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Exrection: Excreted unchanged via the GI tract; can cause constipation. Post-examination (after 24 hours) may be performed to ensure clearance

A

Metallic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Contraindications: Contraindicated in patients with GI perforation, severe swallowing difficulties, severe constipation, or intestinal obstruction

A

Metallic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risks: Risk of impaction or peritonitis if leakage occurs into the abdominal cavity.

A

Metallic salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mode of Administration: Direct injection into lymph nodes (e.g., for lymphography) or during bronchoscopy

A

Oily CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Absorption: Slowly absorbed by the lymphatic system

A

Oily CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Distribution: Phagocytized by polymorphnuclear cells; spreads through the lymphatic and circulatory systems

A

Oily CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

*Metabolism: Metabolized by esterase into sodium iodide in the panreas, liver, and salivary glands

A

Oily CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Excretion: Excreted via urine as inorganic iodine

A

Oily CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Contraindicated in patients with iodine allergies, advanced pulmonary disease, or renal dysfunction.

A

Oily CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risks include adverse reactions to iodine and potential pulmonary embolism.

A

Oily CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Administered intravenously or intrathecally for certain neurological procedures

A

Water-Soluble CM (Ionic and Non-Ionic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Absorption: Absorbed into the bloodstream through intravenous injection; intrathecal CM is absorbed into the bloodstream via the arachnoid villi

A

Water-Soluble CM (Ionic and Non-Ionic)

17
Q

Distribution: Distributed through the blood plasma; may diffuse into the extravascular space, causing potential extravasation.

A

Water-Soluble CM (Ionic and Non-Ionic)

18
Q

Metabolism: Minimal metabolism; remains largely unchanged in the bloodstream.

A

Water-Soluble CM (Ionic and Non-Ionic)

19
Q

Excretion: Primarily excreted via the kidneys through glomerular filtration

A

Water-Soluble CM (Ionic and Non-Ionic)

20
Q

Contraindicated in patients with iodine allergies or renal dysfunction.

A

Water-Soluble CM (Ionic and Non-Ionic)

21
Q

Risks include extravasation, nephrotoxicity, and allergic reactions.

A

Water-Soluble CM (Ionic and Non-Ionic)

22
Q

Mode of Administration: Administered intravenously, commonly used in MRI

A

Gadolinium-Based Contrast Media (GBCM)

23
Q

Absorption: Rapidly absorbed into the bloodstream following injection

A

Gadolinium-Based Contrast Media (GBCM)

24
Q

Distribution: Distributed through the vascular and extracellular, enhancing visualization of tissues with abnormal blood-brain barriers (e.g., tumors)

A

Gadolinium-Based Contrast Media (GBCM)

25
Q

Metabolism: Gadolinium is bound to a chelating agent to reduce toxicity and is not metabolized

A

Gadolinium-Based Contrast Media (GBCM)

26
Q

Excretion: Primarily excreted via the kidneys through glomerular filtration; excreted in the urine within 24 hours

A

Gadolinium-Based Contrast Media (GBCM)

27
Q

Contraindicated in patients with severe renal impairment due to the risk of nephrogenic systemic fibrosis (NSF).

A

Gadolinium-Based Contrast Media (GBCM)

28
Q

Risks include allergic reactions and nephrotoxicity

A

Gadolinium-Based Contrast Media (GBCM)

29
Q

Mode of Administration: Administered intravenously or inhalation, primarily used in ultrasound imaging

A

Microbubble Contrast Agent

30
Q

Absorption: Microbubbles remain within vascular space and are not absorbed by tissues

A

Microbubble Contrast Agent

31
Q

Distribution: Distributed within the bloodstream, enhancing the visualization of blood flow and improving the contrast in ultrasound imaging.

A

Microbubble Contrast Agent

32
Q

Metabolism: Microbubbles do not undergo traditional metabolism. The gas is expelled through normal respiratory processes

A

Microbubble Contrast Agent

33
Q

Excretion: The gas in the microbubbles is exhaled via the lungs, while the shell components (often lipid-based) are metabolized or excreted

A

Microbubble Contrast Agent

34
Q

Contraindicated in patients with severe pulmonary hypertension or right-to-left cardiac shunts

A

Microbubble Contrast Agent

35
Q

Risks include allergic reactions, but complications are rare.

A

Microbubble Contrast Agent